Ask AI

From IV to SC: Multidisciplinary Strategies for Transforming ICI Delivery to Enhance Patient-Centered Care and Ensure Equitable Access

Enhance your understanding of the efficacy and safety of subcutaneous and intravenous routes of immune checkpoint inhibitor administration across tumor types to optimize patient-centric care and improve quality of life through expert-written ClinicalThought commentaries, certified text and video modules with accompanying downloadable slides, and audio podcast.

Share

Program Content

Events

  • Live Event From IV to SC: Managed Care and Clinical Pharmacy Strategies for Integrating Subcutaneous ICI Delivery to Enhance Patient-Centered Care
    From IV to SC: Managed Care and Clinical Pharmacy Strategies for Integrating Subcutaneous ICI Delivery to Enhance Patient-Centered Care
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

Subcutaneous ICI
Expert Thoughts on Integrating Subcutaneous Immune Checkpoint Inhibitor Therapy Into the Care of Patients With Solid Tumors
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 23, 2025

Expires: November 22, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, LLC and ProCE, LLC.

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

Partners

Practicing Clinicians Exchange, LLC

ProCE Banner

ProCE, LLC

ProCE Banner